Skip to content
Research / Cosmetic Grade
BEXO·CORE
Open access

2-sphere vial for topical applications, scalp injection, microneedling integration, and single-site procedures. Suitable for dermatology and aesthetic practice. Each sphere contains the same verified HMSC exosome cargo as all ExoPearl™ products.

Format2 × ExoPearl™ / vial
Total exosomes≥ 20 billion
StorageAmbient · 12 months
AdministrationTopical · Intradermal · Scalp
DocumentationCoA per batch
Enquire
Clinical Protocol Grade
BEXO·PRIME
Licensed practitioners

20-sphere vial for intravenous administration. Designed for longevity clinics and regenerative medicine practices operating under physician oversight. Research indicates that IV-administered HMSC exosomes distribute systemically, with investigational interest in immunomodulatory and anti-inflammatory pathways.

Format20 × ExoPearl™ / vial
Total exosomes≥ 200 billion
Viral screen14-pathogen panel per donor
AdministrationIV · Physician required
DocumentationCoA · Lot-traceable
View Full Details Enquire
Neurological Specialist
BEXO·NEURO
Specialist access

Triple-concentration formulation enriched for neuroprotective microRNA and neurotrophic cargo. Investigational interest centres on stroke recovery support, TBI protocols, and peripheral nerve repair. Research indicates that miR-21 and BDNF cargo may contribute to neuroprotective signalling pathways.

Format3 × ExoPearl™ / vial
Total exosomes≥ 30 billion
Key cargomiR-21 · miR-146a · BDNF · GDNF
CharacterisationNTA · TEM · RNA-seq
AdministrationIV · Intranasal · Specialist
DocumentationCoA · Specialist protocol
View Full Details Enquire

Product Comparison

Specification BEXO·CORE BEXO·PRIME BEXO·NEURO
Format 2 spheres / vial 20 spheres / vial 3 spheres / vial
Total Exosomes ≥ 20 billion ≥ 200 billion ≥ 30 billion
Grade Research / Cosmetic Clinical Protocol Neurological Specialist
Administration Topical · Intradermal · Scalp IV · Physician required IV · Intranasal · Specialist
Key Cargo Standard HMSC profile Standard HMSC profile miR-21 · BDNF · GDNF
Storage Ambient · 12 months Ambient · 12 months Ambient · 12 months
Access Level Open access Licensed practitioners Specialist access
Documentation CoA per batch CoA · Lot-traceable CoA · Specialist protocol
Selection Guide

Choosing the right formulation.

BEXO·CORE is designed for dermatology and aesthetics practitioners performing topical procedures, scalp treatments, and microneedling protocols. With two ExoPearl™ spheres per vial, CORE is sized for single-site procedures where investigational exosome biologics are applied topically or via intradermal delivery. It carries an open access designation, meaning credential verification is streamlined and no specialist medical licence is required beyond standard practitioner registration.

BEXO·PRIME is the formulation of choice for longevity clinics, integrative medicine practices, and regenerative medicine centres operating IV protocols under physician oversight. At 20 spheres per vial, PRIME provides the volume required for intravenous administration. Research indicates that systemically delivered HMSC exosomes distribute across multiple tissue compartments, with investigational interest in their immunomodulatory, anti-inflammatory, and regenerative signalling potential. PRIME requires practitioner licence verification and is restricted to qualified physicians.

BEXO·NEURO is formulated for neurologists, rehabilitation specialists, and clinicians running investigational protocols for stroke recovery, traumatic brain injury support, and peripheral nerve repair. The triple-concentration formulation is enriched for neuroprotective microRNA (miR-21, miR-146a) and neurotrophic factors (BDNF, GDNF) that research indicates may contribute to neuroprotective and neuroplastic signalling pathways. NEURO is supplied under specialist access, requiring documented neurological or rehabilitation credentials.

Shared quality standard. All three formulations are manufactured from the same verified HMSC source cells using the same ExoPearl™ cryo-formation process, under the same GMP conditions. Every batch undergoes identical characterisation (NTA, TEM, ELISA, RNA-seq) and sterility testing (USP <71>). The products differ in concentration, enrichment profile, and intended administration route - not in underlying quality or manufacturing rigour. All products share the same 12-month ambient stability.

Ready to select the right formulation?

Apply for a practitioner or research account. Full documentation provided on activation.